EGFR and glioblastoma: In GBM cells, OPCML loss elevated p-AKT/p-mTOR, and PI3K blockade reversed these readouts, suggesting that OPCML loss may contribute to the activation of this pathway, which is already altered by EGFR amplification/mutation and PTEN loss (13).